Should the development of new antibiotics be a public health priority?
Harbarth
Stephan
S
Infection Control Program and Division of Infectious Diseases, University of Geneva Hospitals, Geneva, Switzerland. stephen.harbarth@hcuge.ch
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D035843:Biomedical Research / Q000458:organization & administration; D004352:Drug Resistance, Microbial; D004363:Drug Utilization; D006292:Health Priorities; D006801:Humans; D011634:Public Health / Q000379:methods*
D000900:Anti-Bacterial Agents